Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma

Tumor protein 53 (TP53) mutation predicts an unfavorable prognosis in diffuse large B-cell lymphoma (DLBCL), but the molecular basis for this association remains unclear. In several malignancies, the cytidine deaminase apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) has been rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xuzhao, Wu, Zhaoxing, Hao, Yuanyuan, Yu, Teng, Li, Xian, Liang, Yun, Li, Jinfan, Huang, Liansheng, Xu, Yang, Li, Xiuzhen, Xu, Xiaohua, Wang, Weiqin, Xu, Genbo, Zhang, Xiaohong, Lv, Qinghua, Fang, Yongming, Xu, Rongzhen, Qian, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112561/
https://www.ncbi.nlm.nih.gov/pubmed/35592333
http://dx.doi.org/10.3389/fimmu.2022.888250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112561/
https://www.ncbi.nlm.nih.gov/pubmed/35592333
http://dx.doi.org/10.3389/fimmu.2022.888250

Ejemplares similares